Prof. Anjana Munshi

Contact Info
Prof. Anjana Munshi
9872694373
Prof. Anjana Munshi

HoD, Department of Human Genetics and Molecular Medicine, School of Health Sciences

Director, Research and Development Cell, Central University of Punjab

Qualification

PhD from Department of Biosciences, University of Jammu (Genetics and Cytogenetics), (1992)

M.Phil. from Department of Biosciences, University of Jammu, (Genetics and Cytogenetics), (1989)

M.Sc. from Department of Biosciences, University of Jammu (Specialization in Cytogenetics), (1988)

Experience
Teaching Experience (29 years)
  • Assistant Professor, Banasthali Vidyapeeth, Rajasthan,
  • Department of Genetics, Shadan Institute of Post Graduate Studies, Osmania University, Hyderabad,
  • Department of Molecular Biology, Institute and Genetics and Hospital for Genetic diseases, Osmani University, Hyderabad,
  • Department of Human Genetics and Molecular Medicine, Central University of Punjab Bathinda
Research Experience (30 Years)
Administrative Experience (14 Years)
  • Head, Department of Genetics, Shadan Institute of Post Graduate Studies, Osmania University, Hyderabad
  • Head, Department of Molecular Biology, Institute and Genetics and Hospital for Genetic diseases, Osmani University, Hyderabad
  • Head, Department of Human Genetics and Molecular Medicine, Central University of Punjab Bathinda (Former)
  • Dean, School of Health Sciences, Central University of Punjab Bathinda (Former)
  • Dean Research, Central University of Punjab Bathinda
  • Presiding Officer, ICC,  Central University of Punjab Bathinda
  • Chief Vigilance Officer,  Central University of Punjab Bathinda
  • EC Member and AC Member, Central University of Punjab Bathinda (Former)
  • Chairperson, SC/ST Cell, Central University of Punjab Bathinda
Research Area

Multiple omics approaches to complex genetic diseases like Stroke, Diabetes and Breast Cancer. Hemoglobinopathies and modifier genes in thalassemia and sickle cell anaemia. Shared genetic susceptibility between Migraine and Epilepsy. Paediatric rare genetic diseases.

Research Interests

Epidemiology and Genomics of Stroke and its Subtypes, Pharmacogenomics of Stroke and Epilepsy, Genomics of Breast Cancer, Pharmacogenomics of Breast Cancer and Diabetes, Molecular basis of Cancer, Hemoglobinopathies and Modifier genes in thalassemia, Shared Genetic basis of Epilepsy and Migraine. Paediatric Rare Genetic Genetic Disorders.

 

 

Research Grants/Projects
  • “Genetic Polymorphism associated with stroke in a South Indian Population” funded by ICMR in collaboration with CCMB and NIMS, Hyderabad, has been completed (2010-13; 37 Lakhs).
  • Training Programme “Prevention of Genetic Disorders and Birth Defects” (for PHC doctors of Andhra Pradesh) Organized by Rajiv Vidya Mission, SSA and Institute of Genetics and Hospital for Genetic Diseases (funded by Heath and Family Welfare, Govt. of Andhra Pradesh)Rs.18Lakhs. (Co-PI)
  • “Amelioration of the Severity of β-thalassemia by Modifier Genes” (2014-2017, 37Lakhs) funded by DBT has been completed.
  • “Insilico Screening of all functional genes in the human genome for the detection of deleterious SNPs for association studies”(ICMR) (30.57Lakhs) (2015-2018)has been completed
  • Migraine and Epilepsy Shared GENEtic Susceptibility (MEGENE) Project in Punjab” (2021-2024, 7940818 Lakhs) funded by ICMR. (ongoing)
  • Mission Program in Pediatric Rare Genetic Diseases. Funded by DBT. ( 1 Crore 10 Lakhs) (5 years).
  • Coordinator of university level DST-PURSE project entitled “Multiomics approach decipher the mechanism involved in Breast Cancer Development, Progression and Development of novel therapeutic strategies.” (2024-2028, Eight Crore Forty Seven Lakh Thirty Seven Thousand Four Hundred Forty). (ongoing)
Professional Affiliation
  • Central University of Punjab
  • Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Hyderabad
  • Shadan Institute of Post Graduate Studies, Osmania University, Hyderabad
  • Banasthali Vidyapeeth Rajasthan

 

 

 

Professional Recognition/Awards/Scholarships
  • Qualified NET conducted by UGC and CSIR, New Delhi. (1993)
  • Awarded SRF by CSIR. (1993)
  • Qualified NET (Genetics) conducted by Agricultural Scientists Recruitment Board, New Delhi. (1994)
  • Awarded Research Associateship by CSIR. (1994)
  • Life Member Indian Society of Human genetics. (2008)
  •  Life Member Third World Organization for Women in Science. (2008)
  • The review entitled “Histone Modifications Dictate Specific Biological Readouts” was awarded as JGG Excellent Review Paper with a bonus of RMB 3000 and a medal. (2015) 
  •  Elected EC member, Indian Society of Human Genetics. (2015-2018)
  • Life member, All India Congress of Cytology and Genetics. (2016)
  • Life member, Indian Science Congress (2015)
  • Former Member IQAC, Central University of Punjab
  • Member World Stroke Rights Bill.
  • Member EC (former) and AC, Central University of Punjab.
  • Certificate of Commendation for Research Publications with CIF more than 15 in the year 2014-2015.
  • Awarded best researcher award for cumulative impact factor more than 15 by CUPB (2017-18).
  • Awarded best researcher award for cumulative impact factor more than 15 by CUPB (2018-19).
  • Certificate of Commendation for Research Publications with CIF more than 20 as corresponding author in the year (2021-22).
  • Certificate of Commendation for a Research grant of more than 1 Crore (2021-22).
  • Awarded for the Roll of Honour of the University for getting Five Commendation Certificate on February 28, 2023.
  • Instrumental in procuring a DST FIST grant (96 lakhs), for the Department of Human Genetics Molecular Medicine, Central University of Punjab, Bathinda..
  • Instrumental in procuring Rs 5 crore grant for establishing ITBI (incubation cell) under the DST NIDHI Scheme being established at CUPB 
  • Instrumental in procuring DST PURSE grant (8.82 crore) university level.
  • PI from Punjab for the nationwide mission programme on Paediatric Rare Diseases funded by DBT (14 Centres included).
Research Collaboration

Internal

  • Dr Sandeep Singh
  • Prof Raj Kumar

External

  • Dr. Sulena, Guru Gobind Singh Medical College and Hospital, Faridkot, Punjab, India
  • Dr. Sushil Kotru and Dr. Rajesh Vashistha, Maxx Super Specialty Hospital, Bathinda
  • Dr Gagandeep Singh, DMCH Ludhiana, Punjab
  • Dr Jayraj Pandian, CMC, Ludhiana, Punjab
  • Dr K. Thangaraj, Director CDFD, Hyderabad
Publications
Publications
  1. Yadav, P., Beura, S., Panigrahi, A. R., Kulkarni, P. P., Yadav, K. M., Munshi, A., & Singh, S.K. (2024). Lysophosphatidylcholine: An inducer of Oxidative Stress & Calcium-Mediated Mitochondrial Dysfunction and Cell Death in Human Blood Platelets.  Cell Biology International. (Impact Factor- 3.9)
  2. Jena, L., Kaur, P., Singh, T., Sharma, K., Koru, S., Mushi, A., (2024). Gene Expression Analysis in T2DM and its associated microvascular diabetic complications: Focus on Risk Factor and RAAS Pathway. Molecular Nuerobiology. (Imapct Factor- 5.686) (accepted for publication)
  3. Banerjee, S., Zhao, Q., Wang, B., Qin, J., Yuan, X., Lou, Z., Zheng, W., Li, H., Wang, X., Cheng, X., Zhu, Y., Lin, F., Yang, F., Xu, J., Munshi, A., Das, P., Zhou, Y., Mandal, K., Wang, Y., Ayub, M., … Li, C. (2024). A novel in-frame deletion in KIF5C gene causes infantile onset epilepsy and psychomotor retardation. MedComm, 5(4). (Impact Factor- 9.9).
  4. Singh, P., Singh, J., Peer, S., Jindal, M., Khokhar, S.,  Ludhiadch, A., & Munshi, A. (2023). Assessment of Resting-state functional Magnetic Resonance Imaging Connectivity among Patients with Major Depressive Disorder: A Comparative Study. Annals of Neurosciences. (Accepted)
  5. Kaur, P., Kotru, S., Tuteja, L., Ludhiadch, A., & Munshi, A. (2023). Role of SGLT2 Inhibitors in Diabetes Management: Focus on HbA1c Levels, Weight Loss and Genetic Variation. Journal of Medical and Health Studies.
  6. Sahu, P., Chaturvedi, P., Khan, R., Munshi, A., & Singh, G. (2023). Translation and Validation of ID-migraine Questionnaire to North-Indian vernacular languages. Annals of Indian Academy of Neurology. (Impact Factor 1.714)
  7. Ludhiadch, A., Sulena, S., Singh, S., Chakraborty, S., Sharma, D., Kulharia, M., & Munshi, A. (2023). Genomic Variation Affecting MPV and PLT count in association with development of Ischemic Stroke and its Subtypes. Molecular Neurobiology. (Impact Factor 5.686)
  8. Vasudeva, K., Sulena., & Munshi, A. (2023). Evaluation of I/D polymorphism of ACE in association with development of ischemic stroke in a North Indian population. International Journal of Environment Science and Technology. 17, 1-8. (Impact Factor 3.519)
  9. Ludhiadch, A., Yadav, P., Singh, S. K., Sulena., & Munshi, A. (2022). Evaluation of Mean Platelet Volume and Platelet Count in Ischemic stroke and its subtypes: Focus on degree of disability and thrombus formation. International Journal of Neuroscience, 1-12. (Impact factor 2.59)
  10. Gupta P., Gupta S., Sinha. S.,, Sundaram, S., Shashi V. K., & Munshi, A. (2022). In silico phytochemical repurposing of natural molecules as entry inhibitors against RBD of the spike protein of SARS-CoV-2 using molecular docking studies.  Int. J. of Computational Biology and Drug Design. 15(4), 267-288 (Impact factor 0.145 ).
  11. Mehta, V., Meena, J., Kasana, H., Munshi, A., & Chander, H. (2022). Prognostic significance of CHAC1 expression in breast cancer. Molecular biology reports, 49(9), 8517–8526. (Impact factor  2.742)
  12. Kumar, V., Sood, A., Munshi, A., Gautam, T., & Kulharia, M. (2021). Geometrical and electro-static determinants of protein-protein interactions. Bioinformation, 17(10), 851.
  13. Kaur, M., Mehta, V., Arora, S., Munshi, A., Singh, S., & Kumar, R. (2021). Design, Synthesis and Biological Evaluation of New 5‐(2‐Nitrophenyl)‐1‐aryl‐1H‐pyrazoles as Topoisomerase Inhibitors. ChemistrySelect, 6(26), 6644-6651. (Impact factor 2.307)
  14. Kalra, S., Joshi, G., Kumar, M., Arora, S., Kaur, H., Singh, S., Munshi, A. & Kumar, R. (2020). Anticancer potential of some imidazole and fused imidazole derivatives: Exploring the mechanism via epidermal growth factor receptor (EGFR) inhibition. RSC Medicinal Chemistry, 11(8), 923-939.( Impact factor 4.31)
  15. Prajapati, L., Khandelwal, R., Yogalakshmi, K. N., Munshi, A., & Nayarisseri, A. (2020). Computer-aided Structure prediction of Bluetongue Virus coat protein VP2 assisted by Optimized Potential for Liquid Simulations (OPLS). Current topics in medicinal chemistry, 20(19), 1720-1732. (Impact factor  3.57)
  16. Kaur, R. P., Kumar, V., Shafi, G., Vashistha, R., Kulharia, M., & Munshi, A. (2019). A study of mechanistic mapping of novel SNPs to male breast cancer. Medical Oncology, 36(8), 1-7. (Impact factor  3.738 )
  17. Singla, H., Kaur, R. P., Shafi, G., Vashistha, R., Banipal, R. P. S., Kumar, V., & Munshi, A. (2019). Genomic alterations associated with HER2+ breast cancer risk and clinical outcome in response to trastuzumab. Molecular biology reports, 46(1), 823-831. (Impact factor 2.742)
  18. Kaur, R. P., Banipal, R. P. S., Vashistha, R., Dhiman, M., & Munshi, A. (2019). Association of elevated levels of C-reactive protein with breast cancer, breast cancer subtypes, and poor outcome. Current problems in Cancer, 43(2), 123-129. (Impact factor - 3.698)
  19. Madhulatha, G., Das, S., Venkateswarlu, N., Pujar, A., Jyothy, A., & Munshi, A. (2018). GSTM1 and GSTT1 null polymorphism and antioxidant levels in oral submucous fibrosis, leukoplakia and oral cancer patients among a South Indian Population. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology, 30(2), 169-174. (Impact factor 0.175)
  20. Chhokar, N., Kalra, S., Chauhan, M., Munshi, A., & Kumar, R. (2018). Quinoline-based protein–protein interaction inhibitors of LEDGF/p75 and HIV Integrase: an in Silico study. Current Topics in Medicinal Chemistry, 18(32), 2800-2815. (Impact factor 3.57)
  21. Kalra, S., Kaur, R. P., Ludhiadch, A., Shafi, G., Vashista, R., Kumar, R., & Munshi, A. (2018). Association of CYP2C19* 2 and ALDH1A1* 1/* 2 variants with disease outcome in breast cancer patients: results of a global screening array. European Journal of Clinical Pharmacology, 74(10), 1291-1298. (Impact factor 3.064)
  22. Kalra, S., Joshi, G., Kumar, R., & Munshi, A. (2018). Role of 2-dimensional autocorrelation descriptors in predicting antimalarial activity of artemisinin and its aanalogues: A QSAR study. Current Topics in Medicinal Chemistry, 18(31), 2720-2730. (Impact factor 3.57)
  23. Kaur, R. P., Vasudeva, K., Singla, H., Benipal, R. P. S., Khetarpal, P., & Munshi, A. (2018). Analysis of pro‐and anti‐inflammatory cytokine gene variants and serum cytokine levels as prognostic markers in breast cancer. Journal of Cellular Physiology, 233(12), 9716-9723. (Impact factor 6.513)
  24. Kumar, V., Mahato, S., Munshi, A., & Kulharia, M. (2018). PPInS: a repository of protein-protein interaction sitesbase. Scientific Reports, 8(1), 1-9. (Impact factor  4.997)
  25. Prasad, D. K. V., Prabhakararao, T. S., Satyanarayana, U., Prabha, T. S., & Munshi, A. (2018). Association of Serum Homocysteine and hs-CRP with Idiopathic Generalised Epilepsy and Duration of Antiepileptic Drug Therapy. Journal of Clinical & Diagnostic Research, 12(2).
  26. Kaur, R. P., Shafi, G., Benipal, R. P. S., & Munshi, A. (2018). Frequency of pathogenic germline mutations in cancer susceptibility genes in breast cancer patients. Medical Oncology, 35(6), 1-9. (Impact factor 3.738)
  27. Munshi, A., Khetarpal, P., Das, S., Rao, V., Valecha, M., Bansal, M., & Kumar, R. (2018). Apert's syndrome: Study by whole exome sequencing. Genes & diseases, 5(2), 119-122. (Impact factor 7.376)
  28. Kalra, S., Joshi, G., Munshi, A., & Kumar, R. (2017). Structural insights of cyclin dependent kinases: implications in design of selective inhibitors. European journal of medicinal chemistry, 142, 424-458. (Impact factor 7.088)
  29. Kaur, R. P., Dhiman, M., Vashitstha, R., & Munshi, A. (2017). Serum albumin levels in breast cancer: Correlation with overall survival. Journal of Food & Nutritional Disorders 6(5), (Impact factor 3.09)
  30. Das, S., Kaul, S., Jyothy, A., & Munshi, A. (2017). Role of TLR4 (C1196T) and CD14 (C-260T) polymorphisms in development of ischemic stroke, its subtypes and hemorrhagic stroke. Journal of Molecular Neuroscience, 63(3), 300-307. (Impact factor 2.866)
  31. Joshi, G., Nayyar, H., Kalra, S., Sharma, P., Munshi, A., Singh, S., & Kumar, R. (2017). Pyrimidine containing epidermal growth factor receptor kinase inhibitors: Synthesis and biological evaluation. Chemical biology & drug design, 90(5), 995-1006. (Impact factor 2.873)
  32. Das, S., Kaul, S., Jyothy, A., & Munshi, A. (2016). Association of APOE (E2, E3 and E4) gene variants and lipid levels in ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian population. Neuroscience Letters, 628, 136-141. (Impact factor 3.197)
  33. Panigrahi, I., Kalra, J., Goyad, P., Khetarpal, P., & Munshi, A. (2016). Mutational analysis in Gaucher disease: implications in genetic counseling and management. J Genet Disor Genet Rep 5, 2, 2. (Impact factor  0.32)
  34. Dadheech, S., Madhulatha, D., Jain, S., Joseph, J., Jyothy, A., & Munshi, A. (2016). Association of BCL11A genetic variant (rs11886868) with severity in β-thalassaemia major & sickle cell anaemia. The Indian journal of medical research, 143(4), 449. (Impact factor 5.274)
  35. Das, S., Roy, S., Kaul, S., Jyothy, A., & Munshi, A. (2015). MTHFR gene (C677t) polymorphism in Ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian population. Acta Medica International, 2(2), 28. (Impact factor 0.332)
  36. Shaheen, U., Akka, J., Hinore, J. S., Girdhar, A., Bandaru, S., Sumithnath, T. G., Nayarisseri, A. & Munshi, A. (2015). Computer aided identification of sodium channel blockers in the clinical treatment of epilepsy using molecular docking tools. Bioinformation, 11(3), 131. 
  37. Munshi, A., Das, S., & Kaul, S. (2015). Genetic determinants in ischaemic stroke subtypes: seven year findings and a review. Gene, 555(2), 250-259. (Impact factor 3.913)
  38. Prasad, D. K. V., Shaheen, U., Satyanarayana, U., Surya Prabha, T., Jyothy, A., & Munshi, A. (2014). Association of serum trace elements and minerals with genetic generalized epilepsy and idiopathic intractable epilepsy. Neurochemical research, 39(12), 2370-2376. (Impact factor 3.038)
  39. Puppala, J., Bhrugumalla, S., Kumar, A., Siddapuram, S. P., Viswa, P. D., Kondawar, M., & Munshi, A. (2014). Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease. Indian Journal of Gastroenterology, 33(6), 524-529. (Impact factor 0.663)
  40. R, Patel R P, Das S, Saraf J,   Jyothi A,  Munshi  A. (2014). Interleukin 1ß (+3954, -511 and -31) polymorphism in chronic periodontitis patients from North India. Amirisetty Acta odontologica scandinavica 73(5):343-7. (Impact factor 2.332)
  41. Roy, S., Das, S., Munshi, A., Kaul, S., & Jyothy, A. (2014). Association of-1382A> G CCL11 gene variant with ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian population. Neurology India, 62(4), 387. (Impact factor 2.708)
  42. Das, S., Roy, S., Kaul, S., Jyothy, A., & Munshi, A. (2014). E-selectin gene (S128R) polymorphism in hemorrhagic stroke: comparison with ischemic stroke. Neuroscience letters, 581, 125-128. (Impact factor 3.197)
  43. Prasad, D. K. V., Shaheen, U., Satyanarayana, U., Prabha, T. S., Jyothy, A., & Munshi, A. (2014). Association of GABRA6 1519 T> C (rs3219151) and Synapsin II (rs37733634) gene polymorphisms with the development of idiopathic generalized epilepsy. Epilepsy research, 108(8), 1267-1273. (Impact factor 2.991)
  44. Das, S., Roy, S., Sharma, V., Kaul, S., Jyothy, A., & Munshi, A. (2015). Association of ACE gene I/D polymorphism and ACE levels with hemorrhagic stroke: comparison with ischemic stroke. Neurological Sciences, 36(1), 137-142. (Impact factor 3.307)
  45. Das, S., Roy, S., Kaul, S., Jyothy, A., & Munshi, A. (2014). CRP gene (1059G> C) polymorphism and its plasma levels in ischemic stroke and hemorrhagic stroke in a south Indian population. Inflammation, 37(5), 1683-1688. (Impact factor 4.092)
  46. Roy, S., Das, S., Danaboina, R., Sharma, V., Kaul, S., Jyothy, A., & Munshi, A. (2014). Association of E-selectin gene polymorphism (S128R) with ischemic stroke and stroke subtypes. Inflammation, 37(2), 599-603. (Impact factor 4.657)
  47. Alharbi, K. K., Khan, I. A., Munshi, A., Alharbi, F. K., Al-Sheikh, Y., & Alnbaheen, M. S. (2014). Association of the genetic variants of insulin receptor substrate 1 (IRS-1) with type 2 diabetes mellitus in a Saudi population. Endocrine, 47(2), 472-477. (Impact factor 3.221)
  48. Dadheech, S., Jain, S., Madhulatha, D., Sharma, V., Joseph, J., Jyothy, A., & Munshi, A. (2014). Association of Xmn1− 158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia. Molecular biology reports, 41(5), 3331-3337. (Impact factor 2.742)
  49. Shaheen, U., Prasad, D. K. V., Sharma, V., Suryaprabha, T., Ahuja, Y. R., Jyothy, A., & Munshi, A. (2014). Significance of MDR1 gene polymorphism C3435T in predicting drug response in epilepsy. Epilepsy research, 108(2), 251-256. (Impact factor 2.75)
  50. Dadheech, S., Rao, A. V., Shaheen, U., Hussien, M. D., Jain, S., Jyothy, A., & Munshi, A. (2013). Three most common nonsynonymous UGT1A6* 2 polymorphisms (Thr181Ala, Arg184Serand Ser7Ala) and therapeutic response to deferiprone in β-thalassemia major patients. Gene, 531(2), 301-305. (Impact factor 3.919)
  51. Alharbi, K. K., Khan, I. A., Al-Daghri, N. M., Munshi, A., Sharma, V., Mohammed, A. K., & Syed, R. (2013). ABCA1 C69T gene polymorphism and risk of type 2 diabetes mellitus in a Saudi population. Journal of Biosciences, 38(5), 893-897. (Impact factor 2.795)
  52. Sharma, V., Dadheech, S., Kaul, S., Jyothy, A., & Munshi, A. (2013). Association of ALOX5AP1 SG13S114T/A variant with ischemic stroke, stroke subtypes and aspirin resistance. Journal of the neurological sciences, 331(1-2), 108-113. (Impact factor 4.553).
  53. Koppula, R., Kaul, S., Venkateswar Rao, A., Jyothy, A., & Munshi, A. (2013). Association of serum uric acid level with ischemic stroke, stroke subtypes and clinical outcome. Neurology Asia, 18(4). (Impact factor  0.759)
  54. Sharma, V., Kaul, S., Al-Hazzani, A., Alshatwi, A. A., Jyothy, A., & Munshi, A. (2013). Association of COX-2 rs20417 with aspirin resistance. Journal of thrombosis and thrombolysis, 35(1), 95-99. (Impact factor 5.221)
  55. Babu, M. S., Kaul, S., Dadheech, S., Rajeshwar, K., Jyothy, A., & Munshi, A. (2013). Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. Nutrition, 29(6), 872-875. (Impact factor 4.893)
  56. Munshi, A., Rebekah, P., Tella, S., & Akka, J. (2014). Variants of DHFR, MTHFD1, and MTHFR genes: Relation to CNS malformations. The Journal of Obstetrics and Gynecology of India, 64(1), 24-25. (Impact factor: 0.29)
  57. Munshi, A., Satyanarayana, U., Babu, M. S., Vasundhara, A., Harischandra, Y. V., Krishna, A., ... & Jyothy, A. (2013). A Novel LMNA Mutation in Two South Indian Siblings with Hutchinson-Gilford Progeria Syndrome. International Journal of Genetics, 5(1), 116. (Impact factor 1.629)
  58. Sunitha T, Rebekah Prasoona K, Munshi A, Sujatha M, Surya Prabha T, Jyothy A. (2012). A Rare Occurrence of Concordant Neural Tube Defects in Monozygotic Twins of an Epileptic Woman. Neurology India 60(4):428-429 (Impact factor 1.663)
  59. Munshi, A. (2012). Genetic variation in MDR1, LPL and eNOS genes and the response to atorvastatin treatment in ischemic stroke. Human genetics, 131(11), 1775-1781. (Impact factor 5.881)
  60. Munshi, A., Roy, S., Thangaraj, K., Kaul, S., Babu, M. S., & Jyothy, A. (2012). Association of SNP41, SNP56 and a novel SNP in PDE4D gene with stroke and its subtypes. Gene, 506(1), 31-35. (Impact factor 3.913)
  61. SaiBabu M, Venkateswara Rao A, LakshmanTeja G, Kaul S, JyothyA, Munshi A. (2012). Pharmacogenoinformatics: modeling of p-glycoprotein and novel approach of in silico drug designing based on genetic variation of mdr1 gene involved in statin resistance. International journal of drug discovery. 4(1) 145-152. (Impact factor 0.77)
  62. Munshi, A., Babu, M. S., Kaul, S., Rajeshwar, K., Balakrishna, N., & Jyothy, A. (2012). Association of LPL gene variant and LDL, HDL, VLDL cholesterol and triglyceride levels with ischemic stroke and its subtypes. Journal of the neurological sciences, 318(1-2), 51-54. (Impact factor 4.553)
  63. SrikanthBabu BMV, Pulla Reddy B, SaiPriya VH, Munshi A, Rani HS, Latha GS, Rao VD and Jyothy A. (2012). Cytokine gene polymorphisms in the susceptibility of Acute Coronary Syndrome. Genetic Testing and Molecular Biomarker. 16(5) 359-65 (Impact factor 1.795)
  64. Shafi, G., Hasan, T. N., Syed, N. A., Al-Hazzani, A. A., Alshatwi, A. A., Jyothi, A., & Munshi, A. (2012). Artemisia absinthium (AA): a novel potential complementary and alternative medicine for breast cancer. Molecular biology reports, 39(7), 7373-7379. (Impact factor 2.742)
  65. Babu, M. S., Prabha, T. S., Kaul, S., Al-Hazzani, A., Shafi, G., Roy, S., & Munshi, A. (2012). Association of genetic variants of fibrinolytic system with stroke and stroke subtypes. Gene, 495(1), 76-80. (Impact factor 3.913)
  66. Sharma, V., Kaul, S., Al-Hazzani, A., Prabha, T. S., Rao, P. P. K. M., Dadheech, S., & Munshi, A. (2012). Association of C3435T multi drug resistance gene-1 polymorphism with aspirin resistance in ischemic stroke and its subtypes. Journal of the neurological sciences, 315(1-2), 72-76. (Impact factor 4.553)
  67. Rajeshwar, K., Kaul, S., Al-Hazzani, A., Babu, M. S., Balakrishna, N., Sharma, V., & Munshi, A. (2012). C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome. Inflammation, 35(3), 978-984. (Impact factor 4.657)
  68. Munshi, A., Sharma, V., Kaul, S., Al-Hazzani, A., Alshatwi, A. A., Shafi, G.,. & Jyothy, A. (2012). Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke. Molecular biology reports, 39(2), 1677-1682. (Impact factor 2.742)
  69. Alshatwi AA, Shafi G, Hasan TN, Al-Hazzani A, Alsaif MA, Alfawaz MA, Lei KY and Munshi A. (2011). Apoptosis-Mediated Proliferation Inhibition of Human Breast Cancer Cells by Lemon Citrus Extract. Asia-Pacific Journal of Clinical Oncology. 12(6) 1555-1559 (Impact factor 1.926)
  70. Masoodi, T. A., Shaik, N. A., Shafi, G., Munshi, A., Ahamed, A. K., & Masoodi, Z. A. (2012). Comparative analysis of hemagglutinin of 2009 H1N1 influenza A pandemic indicates its evolution to 1918 H1N1 pandemic. Gene, 491(2), 200-204. (Impact factor 3.913)
  71. Sharma V, Nehru B, Hota B, Sharma S and Munshi A. (2011). Modulatory effect of Curcumin in Pentylenetetrazol induced Kindling in rats. Journal of Pharmacy Research 14 (9)2891-2893 (Impact factor 4.20)
  72.  Hasan, T. N., Shafi, G., Syed, N. A., Alfawaz, M. A., Alsaif, M. A., Munshi, A.,  & Alshatwi, A. A. (2013). Methanolic extract of Nigella sativa seed inhibits SiHa human cervical cancer cell proliferation through apoptosis. Natural product communications, 8(2), 1934578X1300800221. (Impact factor 1.496)
  73. Yasovanthi J, Pulla Reddy B, Karunakar KV, Munshi A, Narasimulu G and Jyothy A.  (2011). Association of Vitamin D receptor gene polymorphisms with BMD and their effect on 1-2-5-dihydroxy Vitamin D3 levels in pre and post-menopausal South Indian women from Andhra Pradesh. Clinical Chimica Acta 412 541–544 (Impact factor 6.315)
  74. Munshi A, Dadheech S, Jain S, Joseph J, Al-HazzaniA,Alshatwi AA, SaiBabu M, Rajeshwar K and Jyothy A. (2011). Lack of association of G779A ZHX-2 gene variant with HbF levels in β- thalassemia major. European Journal of Haematology 86 502-506 (Impact factor 3.674)
  75. Munshi A and Al-Hazzani A. Response to Kountouras . (2011). European Journal of Neurology 18e77. (Impact factor 6.288)
  76. Munshi A, Rajeshwar K, Kaul S, Al-Hazzani A, Alshatwi AA, Shafi G, Balakrishna N and Jyothy A. (2011). Association of Tumor Necrosis Factor-α and Matrix Metalloproteinase-3 gene variants with Stroke. European Journal of Neurology18 1053–1059 (Impact factor 6.288)
  77. Sharma, V., Nehru, B., Munshi, A., Sharma, S., & Khanna, P. (2011). Protective effect of curcumin in behavioral impairment induced by pentylenetetrazol in rats. J Pharm Res, 4(1), 11-14. (Impact factor 4.2)
  78. Masoodi TA, Shafi G and Munshi A. (2010). In-Silico Analysis of Polymerase Basic Protein 2 in Different Strains of Influenza A Virus. Journal of Computational Intelligence in Bioinformatics 3(2) 211-220. (Impact factor 0.338)
  79. Munshi A, Rajeshwar K, Kaul S, SaiBabu M, Anila AN, Alladi S and Jyothy A. (2010). Interleukin-10-1082 Promoter Polymorphism and ischemic Stroke Risk in a South Indian Population. Cytokine 52 221–224 (Impact factor 3.926)
  80. Munshi, A., Sharma, V., Kaul, S., Al-Hazzani, A., Alshatwi, A. A., Manohar, V. R., ... & Jyothy, A. (2010). Estrogen receptor α genetic variants and the risk of stroke in a South Indian population from Andhra Pradesh. Clinica Chimica Acta, 411(21-22), 1817-1821. (Impact factor 6.315)
  81. Reddy P, Babu S, Katunakar V, Yashovanti J, Munshi A, Kumar S, Sharath A and Jyothy A. (2010). Angiotensin converting enzyme gene variant and its levels are risk factorsformyocardialinfarction in a South Indian population. Singapore Medical Journal. 51(7) 576-581 (Impact factor 3.331)
  82. Munshi A, SaiBabu M, Gowhar S, Rajeshwar K, Kaul S and Jyothy A. (2010). Serum Zn depletion in stroke. Methods Find ExpClinPharmacol 32(6) 433-436.
  83. Munshi, A., Sharma, V., Kaul, S., Rajeshwar, K., Babu, M. S., Shafi, G., ... & Jyothy, A. (2010). Association of the− 344C/T aldosterone synthase (CYP11B2) gene variant with hypertension and stroke. Journal of the Neurological Sciences, 296(1-2), 34-38. (Impact factor 4.553)
  84. Munshi, A., Rajeshwar, K., Kaul, S., Chandana, E., Shafi, G., Anila, A. N., ... & Jyothy, A. (2010). VNTR polymorphism in intron 4 of the eNOS gene and the risk of ischemic stroke in a South Indian population. Brain Research Bulletin, 82(5-6), 247-250. (Impact factor: 3.715)
  85. Sharma, V., Nehru, B., Munshi, A., & Jyothy, A. (2010). Antioxidant potential of curcumin against oxidative insult induced by pentylenetetrazol in epileptic rats. Methods and findings in experimental and clinical pharmacology, 32(4), 227-232. 
  86. Rao, P. P. K. M., Munshi, A., Mullapudi, R., Kumar, P. S., Sharath, A., Krishna, G. A., & Sadhnani, M. (2011). The M235T polymorphism of the angiotensinogen gene in South Indian patients of hypertrophic cardiomyopathy. Journal of the Renin-Angiotensin-Aldosterone System, 12(3), 238-242. (Impact factor 4.109)
  87. Jeedigunta, Y., Reddy, P. R. B., Kolla, V. K., Munshi, A., Ananthapur, V., Narasimulu, G., & Akka, J. (2010). Association of estrogen receptor α gene polymorphisms with BMD and their affect on estradiol levels in pre-and postmenopausal women in south Indian population from Andhra Pradesh. Clinica chimica acta, 411(7-8), 597-600. (Impact factor 6.315)
  88. Shafi, G., Munshi, A., Hasan, T. N., Alshatwi, A. A., Jyothy, A., & Lei, D. K. (2009). Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella sativa. Cancer Cell International, 9(1), 1-8. (Impact factor 6.436)
  89. Munshi, A., Babu, M. S., Kaul, S., Shafi, G., Anila, A. N., Alladi, S., & Jyothy, A. (2009). Phosphodiesterase 4D (PDE4D) gene variants and the risk of ischemic stroke in a South Indian population. Journal of the Neurological Sciences, 285(1-2), 142-145. (Impact factor 4.553)
  90. Munshi, A., Kaul, S., Aliya, N., Shafi, G., Alladi, S., & Jyothy, A. (2009). Prothombin gene G20210A mutation is not a risk factor for ischemic stroke in a South Indian Hyderabadi Population. Thrombosis research, 124(2), 245-247. (Impact factor 10.409)
  91. Munshi, A., Anandraj, M. P. J. S., Joseph, J., Shafi, G., Anila, A. N., & Jyothy, A. (2009). Inherited hemoglobin disorders in Andhra Pradesh, India: a population study. Clinica Chimica Acta, 400(1-2), 117-119. (Impact factor 6.315)
  92. Munshi, A., Sultana, S., Kaul, S., Reddy, B. P., Alladi, S., & Jyothy, A. (2008). Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischemic stroke in a South Indian population. Journal of the Neurological Sciences, 272(1-2), 132-135. (Impact factor 4.553)
  93. Munshi, A. (1995). Cytogenetic studies on primary trisomics of Plantago lanceolata L. In Proc. Indian. Natl. Sci. Acad. B Biol. Sci. (Vol. 61, pp. 339-346). (Impact factor 0.282)
  94. Munshi, A. (1994). A novel aneuploid in Plantago lanceolata L. Nucleus, 37, 23-24. (Impact factor 4.59)
  95. Munshi A, Langer A and Kaul AK. (1991). Genetic diversity among Plantagos XXV. Isolation of an autotriploid from a cross between disomic (2nd-12) and trisomic (2n=12+1) plants of P. lanceolata L. The Nucleus 35 (2, 3) 97-100. 
  96. Sareen S, Munshi A, Kaul AK and Langer A. (1990). Studies on primary trisomics of Plantagolanceolata L Genetic diversity among Plantagos XIX. Cytologia. 55 601-608. (Impact factor 1.027)
  97. Sareen S, Munshi A, Kaul A K and Langer A. (1989). An interchange trisomic in Plantagolanceolata L Genetic diversity among Plantagos X. Cytologia 55 357-361 (Impact factor 1.027)

Reviews 

​​​​​

  1. Singh, T., Sharma, K., Jena, L., Kaur, P., Singh, S., & Munshi, A. (2024). Mitochondrial bioenergetics of breast cancer. Mitochondrion, 101951. (Impact Factor- 3.9)
  2. Kumar, A., Choudhary, A., & Munshi, A., (2024). Epigenetic reprogramming of mtDNA and its etiology in mitochondrial diseases. Journal of physiology and biochemistry. (Impact Factor- 3.4)
  3. Dhureja, M., Chaturvedi, P., Choudhary, A., Bansal, P., & Munshi, A. (2024). Molecular insights of Drug Resistance in Epilepsy: Multiomics unveil. Molecular neurobiology. (Impact Factor- 5.686) 
  4. Chhichholiya, Y., Singh, H. V., Vashistha, R., Singh, S., & Munshi, A. (2024). Deciphering the role of KRAS gene in Oncogenesis: Focus on Signaling pathways, Genetic Alterations in 3’UTR, KRAS specific miRNAs and Therapeutic Interventions. Critical Reviews in Oncology/Hematology, 194, (Impact Factor- 6.65)
  5. Chhetri, A., Goel, K., Ludhaidch, A., Singh, P., & Munshi, A. (2024). Role of Imaging Genetics in Alzheimer’s Disease: A Systematic Review and Current Update. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). (Impact factor-3)
  6. Khan, R., Chaturvedi, P., Sahu, P., Ludhiadch, A., Singh, P., Singh, G., & Munshi, A. (2024). Role of potassium ion channels in epilepsy: Focus on current therapeutic strategies. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 23(1), 67-87. (Impact factor -2.824).
  7. Chhichholiya, Y., Singh, H. V., Singh, S., & Munshi, A. (2023). Genetic variations in tumor-suppressor miRNA-encoding genes and their target genes: focus on breast cancer development and possible therapeutic strategies. Clinical and Translational Oncology, 26(1), 1-15.(Impact factor -3.405) 
  8.  Goel, K., Chhetri, A., Ludhiadch, A., & Munshi, A. (2023). Current Update on Categorization of Migraine Subtypes on the Basis of Genetic Variation: a Systematic Review. Molecular Neurobiology, 1-30. (Impact Factor -5.686)
  9. Jindal, M., Chhetri, A., Ludhiadch, A., Singh, P., Peer, S., Singh, J., ... & Munshi, A. (2023). Neuroimaging Genomics a Predictor of Major Depressive Disorder (MDD). Molecular neurobiology, 1-14.(Impact Factor -5.686). 
  10. Sharma, E., Shruti, P. S., Singh, S., Singh, T., Kaur, P., Jodha, B., ... & Singh, S. (2023). Trehalose and its diverse biological potential. Current Protein and Peptide Science, 24(6), 503-517. (Impact Factor - 2.8) . 
  11. Singh, H. V., Das, L., Malayil, R., Singh, T., Singh, S., Goyal, T., & Munshi, A. (2023). Comprehensive analysis of culture conditions governing differentiation of MSCs into articular chondrocytes. Regenerative Medicine, 18(7), 573-590. (Impact factor – 3.210)
  12. Malayil, R., Chhichholiya, Y., Vasudeva, K., Singh, H. V., Singh, T., Singh, S., & Munshi, A. (2023). Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes. Medical Oncology, 40(6), 174.(Impact factor -3.738)
  13. Chhichholiya, Y., Ruthuparna, M., Velagaleti, H., & Munshi, A. (2023). Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood–brain barrier and treatment strategies. Clinical and Translational Oncology, 25(5), 1218-1241. (Impact factor -3.405)
  14.  Ludhiadch, A., Bhardwaj, N., Gotra, P., Kumar, R., & Munshi, A. (2023). Common microRNAs in Epilepsy and Migraine: Their Possibility as Candidates for Biomarkers and Therapeutic Targets during Comorbid Onset of Both Conditions. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 22(5), 698-710.  (Impact factor - 4.388)
  15. Mathew, B. A., Katta, M., Ludhiadch, A., Singh, P., & Munshi, A. (2022). Role of tRNA-derived fragments in neurological disorders: a review. Molecular Neurobiology, 60(2), 655-671.(Impact factor - 5.686).
  16.  Ludhiadch, A., Paul, S. R., Khan, R., & Munshi, A. (2022). COVID-19 induced ischemic stroke and mechanisms of viral entry in brain and clot formation: a systematic review and current update. International Journal of Neuroscience, 133(10), 1153-1166. (Impact factor -2.59) 
  17. Katta, M., Mathew, B. A., Chaturvedi, P., Ludhiadch, A., & Munshi, A. (2022). Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease. Neurological Sciences, 44(1), 19-36. (Impact factor -3.83)
  18. Jakhar, K., Vaishnavi, S., Kaur, P., Singh, P., & Munshi, A. (2022). Pharmacogenomics of GLP-1 receptor agonists: focus on pharmacological profile. European Journal of Pharmacology, 936, 175356. (Impact factor - 5.1). 
  19. Singh, T., Kaur, P., Singh, P., Singh, S., & Munshi, A. (2022). Differential molecular mechanistic behavior of HDACs in cancer progression. Medical Oncology, 39(11), 171. (Impact factor -3.738)
  20. Chaturvedi, P., Khan, R., Sahu, P., Ludhiadch, A., Singh, G., & Munshi, A. (2022). Role of omics in migraine research and management: a narrative review. Molecular Neurobiology, 59(9), 5809-5834. (Impact factor - 5.686)
  21. Kaur, P., Kotru, S., Singh, S., & Munshi, A. (2022). miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms. Journal of physiology and biochemistry, 78(1), 19-37. (Impact factor -5.08).
  22. Suman, P., Chhichholiya, Y., Kaur, P., Ghosh, S., & Munshi, A. (2022). Long non-coding RNAs involved in different steps of cancer metastasis. Clinical and Translational Oncology, 24(6), 997-1013. (Impact factor -3.34)
  23. Kaur, P., Kotru, S., Singh, S., & Munshi, A. (2022). Role of miRNAs in diabetic neuropathy: mechanisms and possible interventions. Molecular neurobiology, 1-14. (Impact factor - 5.686)
  24. Ludhiadch, A., Sharma, R., Muriki, A., & Munshi, A. (2022). Role of calcium homeostasis in ischemic stroke: a review. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 21(1), 52-61.(Impact factor - 4.388)
  25. Chhichholiya, Y., Suryan, A. K., Suman, P., & Singh, S. (2021). SNPs in miRNAs and target sequences: role in cancer and diabetes. Frontiers in Genetics, 12, 793523.(Impact factor -4.772).
  26. Chhichholiya, Y., Suman, P., Singh, S., & Munshi, A. (2021). The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies. Medical Oncology, 38(8), 95. (Impact factor - 3.738)
  27. Kaur, P., Behera, B. S., Singh, S., & Munshi, A. (2021). The pharmacological profile of SGLT2 inhibitors: Focus on mechanistic aspects and pharmacogenomics. European Journal of Pharmacology, 904, 174169. (Impact factor -4.96)  
  28. Gotra, P., Bhardwaj, N., Ludhiadch, A., Singh, G., & Munshi, A. (2021). Epilepsy and migraine shared genetic and molecular mechanisms: focus on therapeutic strategies. Molecular Neurobiology, 58, 3874-3883. (Impact factor -5.686)
  29. Vasudeva, K., Dutta, A., & Munshi, A. (2021). Role of lncRNAs in the development of ischemic stroke and their therapeutic potential. Molecular Neurobiology, 58(8), 3712-3728. (Impact factor -5.686)  
  30. Mehta, V., Chander, H., & Munshi, A. (2021). Complex roles of discoidin domain receptor tyrosine kinases in cancer. Clinical and Translational Oncology, 23(8), 1497-1510. (Impact factor - 3.34) 
  31. Mehta, V., Chander, H., & Munshi, A. (2020). Mechanisms of anti-tumor activity of Withania somnifera (Ashwagandha). Nutrition and Cancer, 73(6), 914-926. (Impact factor: 2.816).
  32. Singla, H., & Munshi, A. (2020). HER2 Tyrosine Kinase Inhibitors in the Sensitization to Cancers Resistant to HER2 Antibodies. Critical Reviews™ in Oncogenesis, 25(3). (Impact factor - 1.04)
  33. Kaur, P., Kotru, S., Singh, S., Behera, B. S., & Munshi, A. (2020). Role of miRNAs in the pathogenesis of T2DM, insulin secretion, insulin resistance, and β cell dysfunction: the story so far. Journal of physiology and biochemistry, 76(4), 485-502. (Impact factor: 5.08)
  34. Ludhiadch, A., Muralidharan, A., Balyan, R., & Munshi, A. (2020). The molecular basis of platelet biogenesis, activation, aggregation and implications in neurological disorders. International Journal of Neuroscience, 130(12), 1237-1249. (Impact factor: 2.59).
  35. Ludhiadch, A., Vasudeva, K., & Munshi, A. (2020). Establishing molecular signatures of stroke focusing on omic approaches: a narrative review. International Journal of Neuroscience, 130(12), 1250-1266. (Impact factor: 2.59).
  36. Vasudeva, K., & Munshi, A. (2020). miRNA dysregulation in ischaemic stroke: Focus on diagnosis, prognosis, therapeutic and protective biomarkers. European Journal of Neuroscience, 52(6), 3610-3627. (Impact factor: 3.698).
  37. Vasudeva, K., Balyan, R., & Munshi, A. (2019). ACE-triggered hypertension incites stroke: genetic, molecular, and therapeutic aspects. NeuroMolecular Medicine, 22, 194-209. (Impact factor: 4.103).
  38. Vasudeva, K., & Munshi, A. (2018). Genetics of platelet traits in ischaemic stroke: focus on mean platelet volume and platelet count. International Journal of Neuroscience, 129(5), 511-522.. (Impact factor:2.59 ).
  39. Singla, H., Munshi, A., Banipal, R. P., & Kumar, V. (2018). Recent updates on the therapeutic potential of HER2 tyrosine kinase inhibitors for the treatment of breast cancer. Current Cancer Drug Targets, 18(4), 306-327. (Impact factor-2.907)
  40. Kaur, R. P., Vasudeva, K., Kumar, R., & Munshi, A. (2018). Role of p53 gene in breast cancer: focus on mutation spectrum and therapeutic strategies. Current pharmaceutical design, 24(30), 3566-3575. (Impact factor: 3.31).
  41. Sharma, B., Kaur, R. P., Raut, S., & Munshi, A. (2018). BRCA1 mutation spectrum, functions, and therapeutic strategies: the story so far. Current problems in cancer, 42(2), 189-207.. (Impact factor: 2.32)
  42. Shailani, A., Kaur, R. P., & Munshi, A. (2018). A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors. Medical Oncology, 35(3), 18.(Impact factor: 3.738).
  43. Lohani, N., Bhargava, N., Munshi, A., & Ramalingam, S. (2017). Pharmacological and molecular approaches for the treatment of β‐hemoglobin disorders. Journal of cellular physiology, 233(6), 4563-4577. (Impact factor: 6.513).
  44. Das, S., & Munshi, A. (2018). Research advances in Apert syndrome. Journal of Oral Biology and Craniofacial Research, 8(3), 194-199. (Impact factor: 0.447).
  45. Vasudeva, K., Chaurasia, P., Singh, S., & Munshi, A. (2017). Genetic signatures in ischemic stroke: focus on aspirin resistance. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 16(9), 974-982. (Impact factor: 4.388).
  46. Singla, H., Ludhiadch, A., Kaur, R. P., Chander, H., Kumar, V., & Munshi, A. (2017). Recent advances in HER2 positive breast cancer epigenetics: Susceptibility and therapeutic strategies. European journal of medicinal chemistry, 142, 316-327.(Impact factor: 7.088).
  47. Singla, H., Kalra, S., Kheterpal, P., Kumar, V., & Munshi, A. (2017). Role of genomic alterations in HER2 positive breast carcinoma: focus on susceptibility and trastuzumab-therapy. Current Cancer Drug Targets, 17(4), 344-356. (Impact factor: 2.907).
  48. Munshi, A., & Mohan, V. (2016). Non-coding RNAs: a dynamic and complex network of gene regulation. Journal of Pharmacogenomics & Pharmacoproteomics, 7(01), 7.( Impact factor: 2.31)
  49. Das S, and Munshi A. (2016). The Role of Genetic Variation in Haemorrhagic Stroke: An Update. Austin Neurology 1(1): 1003. (Impact factor: 2.8).
  50. Munshi A and Sharma V. (2016). Precision medicine in stroke: an ideal model for stroke treatment. Precision medicine 1(1):10-12. Impact factor (5.091)
  51. Khetarpal, P., Das, S., Panigrahi, I., & Munshi, A. (2015). Primordial dwarfism: overview of clinical and genetic aspects. Molecular Genetics and Genomics, 291, 1-15. (Impact factor:2.93).
  52. Das, S., Roy, S., & Munshi, A. (2015). Association between PDE4D gene and ischemic stroke: recent advancements. International Journal of Neuroscience, 126(7), 577-583.(Impact factor:2.59).
  53. Munshi, A., & Sharma, V. (2015). Genetic signatures in the treatment of stroke. Current Pharmaceutical Design, 21(3), 343-354.(Impact factor:3.31).
  54. Prasad, D. K. V., Satyanarayana, U., & Munshi, A. (2013). Genetics of idiopathic generalized epilepsy: An overview. Neurology India, 61(6), 572-577. (Impact factor: 2.708).
  55. Jyothy A, Munshi A. (2013). Genetic Modifiers of Β-Thalassemia-Review. AP Academy of Sciences: Special Issue Women in Science 15(1): 23-27. (Impact factor: 0.205).
  56. Puppala, J., Siddapuram, S. P., Akka, J., & Munshi, A. (2013). Genetics of nonalcoholic fatty liver disease: an overview. Journal of genetics and genomics, 40(1), 15-22. (Impact factor: 5.723).
  57. Prabha, T. S., Sharma, V., Sharma, S., & Munshi, A. (2012). Pharmacogenetics in Epilepsy Treatment-A predictor of therapeutic efficacy. Journal of Pharmacy Research, 5(2), 727-736. (Impact factor: 4.2 ).
  58. Munshi, A., & Ahuja, Y. R. (2010). Genes associated with Alzheimer Disease. Neurology Asia, 15.(Impact factor: 0.759).
  59. Munshi A and Kaul S. (2010). Stroke Genetics-An Overview. Neurology India 58(2):181-187 (Impact factor: 2.708).
  60. Shafi, G., Aliya, N., & Munshi, A. (2010). MicroRNA signatures in neurological disorders. Canadian Journal of Neurological Sciences, 37(2), 177-185. (Impact factor: 2.914).
  61. Ahuja YR, Munshi A and JahanP. (2009). Environmental modifications of epigenetics and its consequences. Proc AP Akademi of Sciences 13(1-4):87-92. (Impact factor: 1.214).
  62. Munshi, A., Shafi, G., Aliya, N., & Jyothy, A. (2009). Histone modifications dictate specific biological readouts. Journal of Genetics and Genomics, 36(2), 75-88.(Impact factor: 5.723).
  63.  Anjana Munshi, A. M., & Duvvuri, V. S. (2008). Nutrigenomics: looking to DNA for nutrition advice. Indian Journal of Biotechnology, 32-40. (Impact factor: 0.324).
  64. Munshi, A., & Kaul, S. (2008). Stroke genetics–focus on PDE4D gene. International Journal of Stroke, 3(3), 188-192. (Impact factor: 6.948).
  65. Munshi, A., & Duvvuri, S. (2007). Genomic imprinting—the story of the other half and the conflicts of silencing. Journal of Genetics and Genomics, 34(2), 93-103. (Impact factor: 5.723).
  66. Jahan P, Munshi A and Ahuja YR. (2006). Stem cells in toxicology. Perspectives in Cytology and Genetics12: 79-81 (Impact factor 0.643).
  67. Munshi A. (2005). The Evil Prions. Advanced Biotech 21-25. 
  68. Jahan P, Munshi A and Ahuja YR. (2004) Regenerative medicine. Perspectives in Cytology and Genetics11: 173-179. (Impact factor 0.643).
Books
  1. DNA Sequencing: Methods and Applications (Intech Publishers, Europe).ISBN 978-953-51-0564-0
  2. Inherited Hemoglobin Disorders (Intech Publishers, Europe) ISBN 978-953-51-2198-5
  3. Human Blood Group Systems and Haemoglobinopathies (IntechOpen) ISBN 978-1-83880-313-1
Book Chapters
  1. Choudhary,  A., Kaur, P., &  Munshi, A. (2023). Nucleic Acid Therapeutic Approaches: Focus on Genetic Disorders. Way forward for Sustainable Future:  Role of Science and Technology. (accepted for publication).
  2. Chaturvedi, P., Sahu P., Khan R., Singh G., and Munshi A. (2023). Principles of Genetic Assessments in Neurological Disorders. 2nd Edition Volune 2 IAN Textbook of Neurology, 1240-1254.
  3. Ludhiadch, A., Yadav U.P., and Munshi A. Currently available COVID-19 management options. Omics approaches and technologies in COVID-19. Elsevier, 2023.
  4. Yadav U.P., Ruthuparna M,Vasudeva K.,Suman P., Munshi A., Kumar S., and Singh S. Natural Compound-Based nanoparticles to Target Free Radicals in Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Springer,2022
  5. Vasudeva K., Kaur P., Munshi A., High-throughput Sequencing Technologies in Metagenomics. Metagenomics to Bioremediation; Applications, Cutting Edge Tools, and Future Outlook, 2022.
  6. Vasudeva, k., Chaturvedi P., Khan, R., Sahu, P., Munshi, A. Targeting Redox Homeostasis of Tumor Cells by Therapeutic Compounds in Cancer. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects. Springer Singapore, 2021.
  7. Kaur, R. P., Kaur, P., & Munshi, A. (2020). Epigenetic Instability Caused by Oxidative Stress Triggers Tumorigenesis. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects, 1-18.
  8. Vasudeva, K., Munshi, A. (2020). Chapter 33: Advances in sequencing technologies. Handbook on Medical Genetics and Genetic Counselling. 2nd Edition (Noble Vision). ISBN No.: 978-81-906227-4-5. Pp 297-303.
  9. Vasudeva, K and Munshi, A. (2020). Genetic Basis in Stroke Treatment: Targets of Potent Inhibitors Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
  10. Munshi, A., Singh A. R., and Singh J. R., (2020). Chapter 1:  The Burden of Genetic Disorders and Role of Advanced Diagnostic, Therapeutic, Screening, and Counseling Approaches in Reducing it. Volume 20. Advances in Genetics Research. ISBN: 978-1-53618-154-8.
  11. Kaur, R. P., Ludhiadch, A. Chakravorty, K. and Munshi, A. (2019).Chapter 21: Single cell omics in non-invasive diagnosis and testing (Including NIPT). Single-Cell Omics. 1st Edition Volume 2. Technological Advances and Applications. eBook ISBN: 9780128175330.
  12. Kaur, R. P., Ludhiadch, A., & Munshi, A. (2019). Single-Cell Genomics: Technology and Applications. Single-Cell Omics, 179-197. doi:10.1016/b978-0-12-814919-5.00009-9
  13. Munshi A and Das S. (2017). Genetic understanding of stroke treatment: potential role for phosphodiesterase inhibitors “Phosphodiesterases-CNS Functions and DiseaseAdvNeurobiol”. 2282-8, Chapter 17(Springer)pp445-461.
  14. Munshi A and Sharma V. (2017). Circulating tumor cells and circulating tumor DNA. “Precision medicine precision medicine: prediction, prevention with personalization” Cat. No.: k29688Chapter 10, CRC press Taylor and Francis).
  15. Sharma, S., Munshi, A., & Sharma, V. (2017). Time to educate physicians and hospital staff in electronic medical records for precision medicine. In Progress and Challenges in Precision Medicine (pp. 217-232). Academic Press.
  16. Munshi A and Sharma V. (2017). Precision medicine in stroke and other neurological disorders“Precision medicine precision medicine: prediction, prevention with personalization” .Cat. No.: k29688 Chapter 2 CRC press Taylor and Francis).
  17. Munshi A, Sharma V. (2016). Safety and ethics in biotechnology and bio-engineering: what to follow and what not. “Omics Technologies and Bio-engineering: towards improving quality of life, Chapter 32 (Academic Press imprint: Elsevier.
  18. Munshi A,Sharma V. (2016).Omics approaches in molecular farming and engineering for edible vaccines “Omics Technologies and Bio-engineering: towards improving quality of life, Chapter 42 (Academic Press imprint: Elsevier)..
  19. Munshi A and Sharma V and Sharma S. (2016).Lessons learned from cohort studies, and hospital based studies and their implications in precision medicine “Progress and Challenges in Precision Medicine”Chapter 12 (Taylor and Francis)
  20. Munshi A, Ahuja YR, Bahadur B. (2015).Epigenetic Mechanisms in Plants: An Overview “Plant Biology and Biotechnology” ISBN 978-81-322-2282-8,Chapter 12(Springer)pp265-278
  21. Hasan TN, Shafi G, Grace L, Tegner J, and Munshi A. (2015).DNA Methylation: An Epigenetic Marker of Breast Cancer Influenced by Nutrients Acting as an Environmental Factor. “Noninvasive Molecular Markers in Gynecologic Cancers”.ISBN 9781466569386 - CAT# K16436, Chapter 6(CRC Press, Taylor and Francis Group) pp 187-202
  22. Munshi A, Dadeech S, Babu S and Khetarpal P. (2015). Modifiers of γ-globin gene expression and treatment of β-thalassemia. “Inherited Hemoglobin Disorders”, ISBN 978-953-51-2198-5, Chapter 7(Intech Publishers, Europe) pp 103-136.
  23. Munshi A. (2014). Nutrigenomics: Gene based personalized nutrition advice.Woman and Food studies from the Indian sub-continent. (Lambert Academic Publishing). ISBN-13: 978-3848430710, Chapter 17, pp 120-135.
  24. Munshi A, Sharma V. (2014). Quality Control and Ethical Issues of Cancer Biomarker discovery. “Cancer Biomarkers: Non-invasive Early Diagnosis and Prognosis ISBN: 978-1-4665-8428-0, Chapter 1“(CRC press) pp 3-17.
  25. Munshi A, Sharma V. (2014). Insilco Disease Models of Breast Cancer. "Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy” ISBN-13: 978-8132208426, Chapter 16 (Springer) pp 315-331
  26. Shafi G, Hasan TN, Syed NA, Paine A, Tegner J, Munshi A. (2014). Breast Cancer MicroRNAs: Clinical Biomarkers for the Diagnosis and Treatment Strategies. “Omics Approaches in Breast Cancer: Towards Next-Generation Diagnosis, Prognosis and Therapy” ISBN-13: 978-8132208426, Chapter 8 (Springer) pp171-182.
  27. Sharma S, Munshi A. (2013). Omics approaches applications in Clinical Trials. Omics for Personalized Medicine (Springer) ISBN 978-81-322-1184-6 Chapter 7, pp 123-146.
  28. Munshi A, Ahuja YR. (2013). Ethical Considerations in Pharmacogenomics. Omics for Personalized Medicine (Springer). ISBN 978-81-322-1184-6 Chapter 8 pp 147-162.
  29. Munshi A, Crotti LB, Sharma V, Sharma S, EspinozaLA. (2013). Pharmacogenomics of Allergy and asthma. “Omics for Personalized Medicine” (Springer) ISBN 978-81-322-1184-6 Chapter 24, pp 529-560.
  30. Munshi A, Krupanidhi S, AhujaYR. (2013).OMICS: Applications in Biomedical, Agricultural, and Environmental Sciences Epigenome. “Genomic response to environmental accentricities” (CRC Press, Taylor and Francis Group) ISBN: 978-1-4665-6281-3, Chapter 2, pp 44-63.
  31. Munshi A, Sharma V. Pharmacogenetics-A treatment strategy for alcoholism. (2012). Pharmacology (Intech Publishers) ISBN 978-953-51-0222-9, Chapter 12, pp 231-254.
  32. Sharma S, Munshi A. (2011). Pharmacogenomics in development of disease specific therapeutic strategies. “Omics-Biomedical Perspective and Applications” (Taylor and Francis publications) ISBN: 978-1-4398-5008-4. Chapter 17, pp 319–332.

EDITORIAL ASSIGNMENTS

  1. Editor, Special Issue, “MicroRNA and Other Small RNAs in Cancer and Human Diseases”, MDPI. (2022). (Impact Factor - 4.141).
  2. Editorial Board Member, Brain Sciences, MDPI (2022). (Impact Factor -3.333).
  3. Associate Editor, Handbook of Oxidative stress in cancer: Therapeutic aspects, Therapeutic implication of natural compounds, (2021). Springer Nature.
  4. Guest Associate Editor,  Frontiers in Genetics Special issue on Developmental Delay and Intellectual Disability, Frontiers, UK (2021).

 

EDITORIAL PUBLISHED 

 

  1. Kalra, R. S., Singh, S., Munshi, A., & Bariwal, J. (2022). Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing. Frontiers in oncology, 12, 1106610. . (Impact Factor - 6.244).
  2. Banerjee, S., Munshi, A., Li, C., & Ayub, M. (2022). Editorial: Developmental delay and intellectual disability. Frontiers in genetics, 13, 934815. (Impact Factor - 4.772).

EDITED BOOKS

 

  1. Munshi, A. (Ed.). (2012). DNA Sequencing - Methods and Applications. InTech. doi: 10.5772/2158
  2. Munshi, A. (Ed.). (2015). Inherited Hemoglobin Disorders. InTech. doi: 10.5772/59742
  3. Erhabor, O., & Munshi, A. (Eds.). (2021). Human Blood Group Systems and Haemoglobinopathies. IntechOpen. doi: 10.5772/intechopen.82992
Research Guidance

PhD Guidance

Degree Awarded- 16

Ongoing- 7

1. Yogita (CSIR-UGC-SRF)

2. Prachi Sahoo (ICMR- Project JRF)

3. Ajay Kumar (DBT-Project Associate)

4. Anita Chaudhary (UGC-JRF)

5. Sohit Kashyap (DST-PURSE Project Associate 1)

As Co-PI

1. Maanvi (Bayer's Fellow)

2. Dr Rajveer Singh 

Post Doctoral Fellow- 2

Awarded- 1

M.Sc. Dissertation Guidance- 

External- 52

Internal- 26

Conference/ Workshops/Seminars Attended
National and International
  1. Studies on B. Chromosomes of PlantagoLanceolata L. - 58th Annual Session of National Academy of Sciences, held at Jammu University, No. 5-7, 1988.
  2. Tetrasomy in PlangatoLanceolata L. - 4th All India Conference on Cytogenetics and Genetics and symposium on cytogenetics of Mulbery and Silk Worm, Bangalore.
  3. Regenerative Medicine – Perspectives in cytology and genetics 2002.
  4. Stem cells in toxicology – 12th All India Congress on Oncology and Genetics 2005, Mumbai.
  5. National Seminar on “Recent Advances in Biotechnology & Bioinformatics” July 2006 organized by SCBT, Hyderabad.
  6. National Seminar on “Women in Science & Technology” organized by TWOWS, Sept, 2006, IICT, Hyderabad.
  7. International symposium on “Chromosomes to Genome” organized by CCMB, Hyderabad from 3rd to 5th July 2007.
  8. National seminar on “Genome analysis perspective in the post genomic era and its relevance to society” organized by MGNIRSA, Hyderabad from 26th to 28th Oct.2007.
  9. AP Science Congress organized by AP Academy of Sciences and OU From14-16 November, 2008.
  10. Presented a poster on “Phoshodiesterase 4D genetic variants and risk for ischemic stroke in South Indian population” in Fourth National Congress of Indian Stroke Association. All India Stroke meeting organized by Nizam’s Institute of Medical Sciences, Hyderabad on 14&15th of March 2009. 
  11. Presented a poster on “Association of Angiotensin converting enzyme insertion/deletion polymorphism and Prothrombi G20210A mutation with ischemic stroke in South Indian population” in Fourth National Congress of Indian Stroke Association. All India Stroke meeting organized by Nizam’s Institute of Medical Sciences, Hyderabad on 14&15th of March 2009. 
  12. Presented a poster on “Polymorphism of Pro and anti-inflammatory genes and stroke risk in a South Indian population” in Science and technology: Its role in the changing global scenario, 2nd AP Science congress 2009, organized by Andhra Pradesh Akademi of Sciences and Sri venkateshwaraUniversity,Tirupati on 14th-16th of November 2009.
  13. “National seminar on Recent Advances in Development of Biomarkers for Cancer Prognosis and Treatment” organized by School of human research and genetic disorders& school of biotechnology, MahathmaGandhi national institute of research and social action (MGNIRSA), Hyderabad on 22nd-24th of January 2010. 
  14. Presented a poster on “Genetic variation at the Human Tissue-Type Plasminogen Activator (tPA) locus and the risk of Stroke”in 41st annual meeting of Environmental Mutagen society organized by EMS on October 23-27, 2010 at Omni Fort Worth, Texas, USA.
  15. A talk on “Nutrigenomics: Gene based personalized nutrition advice”  in National seminar cum workshop on Food and women organized by Sarojininaiducentre for women studies, Mahatma Gandhi national institute of research and social action (MGNIRSA), Hyderabad on 21st&22nd of January 2011.
  16. National Conference on “Nanobiotechnology: Emerging Trends and Applications in Microbiology” organized by  School of microbiology of  Mahatma Gandhi national institute of Research and social action (MGNIRSA), Hyderabad on 4th-6th February 2011.  
  17. “Association of 1347 G/A cytochrome P450 4F2 (CYP4F2) gene variant with hypertension and stroke” in International conference on genomics, genetic diseases and diagnosis and XXXVI annual conference of the Indian society of human genetics organized by Indian society of human genetics and Manipal life sciences centre, Manipal on 14th-16th of February 2011.
  18. “Dr. KJR Murthy memorial international seminar on Scientific and clinical aspects of tuberculosis” organized by BhagwanMahavir Memorial Trust, Hyderabad, Andhra Pradesh on 15th February 2012.
  19. “Genetic variation of Multi drug resistance gene-1 (C3435T) in stroke patients and Aspirin resistance” in national conference on “Biomarkers for diseases-prospects and challenges” organized by Centre for Biotechnology and bioinformatics (CBB) School of life sciences (SLS), Jawaharlal Nehru Institute of Advanced Studies (JNIAS), Hyderabad, Andhra Pradesh on 24-25th February, 2012.  
  20. Participated in one day seminar and work shop on “Caring for children with special needs-A holistic approach” organized by Institute of Genetics and Hospital for Genetic Diseases, OU, Nireekshana ACET, Hyderabad and Kimmy’s House, Colorado, USA on 27th February, 2012.
  21. Reoriantation programme on “Research methodology for Ph.D guides” conducted at Dr. NTR University of Health Sciences, Vijayawada, Andhra Pradesh from 9th to 13th July, 2012.
  22. Delivered an invited talk on “Role of high throughput technologies in the management and control of the complex diseases”  in the International conference on Biotechnological innovations towards global development, organized byDepartment of Biotechnology&Bioinformatics, Bishop Heber College (Autonomous), Tiruchirapalli, Tamil Nadu  on 9th& 10thof January 2013.
  23. Oral presentation on “Estrogen receptor α genetic variants and the risk of stroke in pre- and postmenopausal women” in International Conference on Women in Science and Technology in the Arab Countries on April 21-23, 2013 organized by Kuwait Institute for Scientific Research (KISR), Kuwait.
  24. Invited Talk on “Recent Advances in the understanding of Genetic Architecture of Complex DiseasesUsing High Throughput Technologies” in Nation Seminar on Emerging Trends Challenges and Innovative Approaches in Clinical Research in India organized by BhagavanMahavirHospital on 27th-28th April at Hyderabad.
  25. Invited talk on “Genetic influences in the pathogenesis of multifactorial ischemic stroke and its subtypes” in NeuroUpdate organized by Calcutta National Medical College, Govt. of West Bengal & CSIR-Indian Institute of Chemical Biology on 28th -29th November, 2014. 
  26. Attended “Recent Trends in Molecular Medicine” organized at Central University of Punjab, Bathinda, 2014.
  27. Invited talk on “PDE4D gene and ischemic stroke: Potential role for Phosphodiesterase inhibitors” New Frontiers in Diagnosis & Management of Genetic Diseases organized by Institute of Genetics & Hospital for Genetic Diseases, Osmania University, Hyderabadon 29th -30th of January, 2016.
  28. Chaired a session “Epigenetics and Developmental Genetics” in 41st meeting of Indian Society of Human Genetics, Annual meeting and International conference entitled celebrating Genetics–The Human Way. Organized by Vision Research Foundation, Chennai on 3rd-5th March, 2016.
  29. Presented two posters in 42nd meeting Indian Society of Human Genetics & International Symposium on trends in Human Genetic Research & Management, IISC, Bangalore 2-4th March, 2017.
  30. Vasudeva, K. &Munshi, A. (15th October, 2018) presented a poster entitled "Genomic alterations in ischemic stroke and its subtypes: Results of global screening array" in 1st National Biomedical Research Competition-2018 held at AIIMS, Rishikesh.
  31. Ludhiadch, A. &Munshi, A. (15th October, 2018) presented a poster entitled "Genetics of platelet traits in ischemic stroke: Focus on mean platelet volume and count" in 1st National Biomedical Research Competition-2018 held at AIIMS, Rishikesh.
  32. Vasudeva, K. &Munshi, A. (31-01 February, 2019) presented a poster entitled "Genetic signatures in the development of ischemic stroke and its subtypes: Results of Global screening array validated by PCR-RFLP” in 44th annual meeting of the Indian society of human genetics at National Institute of Biomedical Genomics, Kolkata, India.
  33. Kaur, P. & Munshi, A. (31-01 February, 2019) presented a poster entitled "Design of Non glycosidic SGLT2 inhibitors as Anti-diabetic drugs” in 44th annual meeting of the Indian society of human genetics at the National Institute of Biomedical Genomics, Kolkata, India.
  34. Delivered an invited talk on "Genomic signatures in ischemic stroke with disease susceptibility and outcome in the J&K women science congress entitled "Research and Women in Science, Technology and Mathematics- Representation, Challenges and Opportunities at P.G. College for Women Gandhi Nagar, Jammu, 26-28 Feb, 2019.
  35. Delivered an invited talk on "Genomic signatures in the development of ischemic stroke its subtypes and treatment outcome" Golden Jubilee National Seminar on Genetics of Complex Diseases at Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab on March 29, 2019.
  36. Participated in the Assessors' Orientation Programme on 23rd April’ 2019 at Panjab University, Chandigarh.
  37. Delivered two invited lectures on "Genomic contributions in the development of ischemic stroke its subtypes and treatment outcome" and “Methods of Detection of Genetic Disorders” in a Refresher Course in Life Sciences 23 July-5th August, 2019 organized by UGC-Human Resource Development Centre, University of Jammu (UGC-HRDC) in collaboration with Department of Botany.
  38. Kaur, P. & Munshi, A. (1 Feb and 2 Feb, 2020) Presented a poster entitled "Assessment of Hypogonadism in men with Type 2 Diabetes Mellitus – A cross sectional observational study" at SPEEDCON 2020 organized by Society of Promotion of Education in Endocrinology and Diabetes (SPEED).
  39. Delivered an invited talk Virtually on “The art of Scientific writing and Project designing” in faculty Development Program, on 20th, June,2020 organized by Little Flower Degree College, Osmania University, Hyderabad.
  40. Delivered a talk entitled “From a biology researcher to an academic administrator” in the webinar Women in Science, Education and Research organised by School of Life Sciences, Central University of Himachal Pradesh, India on 24th February 2021.
  41. Delivered an expert talk on “In-vitro and In-vivo Animal Models of Hemorrhage Stroke and Therapeutic Strategies” at Internnio, Shri S. K. Patel College of Pharmaceutical Education and Research, Gujarat, India on 7th and 8th August 2021, GUJCOST Sponsored Two days National workshop on In-vitro and in-vivo models in neuro-psychological screening
  42. Presented ePoster entitled “Evaluation of genomic alterations affecting platelet volume, count and aggregation in association with development of ischemic stroke and its subtypes” at European Stroke Organisation Conference (ESOC-2021) held virtual at Helsinki, Finland.
  43. Delivered two talks entitled “Stroke “The Brain Attack” (21st January) and “The Art of Scientific Writing and Project Designing” (24 January) in “Refresher Course in Life Sciences” organised by Department of Botany, University of Jammu sponsored by the UGC-HRDC, through online platform from January 19, 2022 to February 02, 2022. 
  44. Delivered a talk entitled “Genomic signatures of Ischemic stroke susceptibility and Drug response” at 46th Annual Conference of Indian Society of Human Genetics (ISHG) held virtually between 8th and 9th of April, 2022. Manipal School of Life Sciences, MAHE, Manipal.
  45. Delivered a talk on “DNA ‘The Blueprint of Life’ in a webinar on “Watson and Crick DNA Model Commemoration Day” on April 25, 2022 organized by Pushpa Gujral Science City, Kapurthala.
  46. Kaur, P. & Munshi, A.(30TH April and 1st May, 2022). Presented a poster entitled “Evaluation of the association of genomic alterations associated with variation in inter-individual response to SGLT2 inhibitors in Type 2 diabetic patients”   in the 5th annual conference of SPEED – SPEEDCON 2022.
  47. Delivered a talk on “Stroke The Brain Attack” in a Two-Week Online Refresher Course in Basic & Applied Sciences organised by the UGC-Human Resource Development Centre, Guru Nanak Dev University, Amritsar” on November 11, 2022. 
  48. Delivered a talk on “Realtime Polymerase Chain Reaction (RT-PCR)” in Seven days STUTI workshop on Spectroscopic, Chromatographic, Bioanalytical & Imaging Techniques at Central University of Punjab in collaboration with Amity University, sponsored by Department of Science and Technology on December 02, 2022.
  49. Delivered a talk on “Accessing markers and Genetic profiling Bench to Bedside and vice-versa” on March 1st 2023 in one day Webinar on Markers and Genetics in Anaesthesia Bench to Bedside organised by Indian College of Anesthesiologists.
  50. Delivered a talk on “New Molecular Diagnostic approaches: Focus on Monogenic Disorders” on March 3rd 2023 at International Conference on Biotechnology and Human Welfare: Vision 2030 and Beyond organised by Department of Biotechnology Chaudhary Devi Lal University, Sirsa, Haryana.
  51. Delivered a talk on “Single gene disorders: focus on new molecular diagnostic approaches” in National Workshop on Next-Generation Sequencing Data Analysis in Central University of Punjab, Bathinda on 9th March 2023.
  52. Kaur, P. & Munshi, A. (March 11-12, 2023) Presented a poster entitled “Role of SGLT2 inhibitors in diabetes management: Focus on HbA1c levels, weight loss and genetic variation”, at PKPDCON-2023 at AIIMS, Bathinda organsized by Society of YounG Biomedical Scientist India and the poster was selected for the best poster presentation Award.
  53. Delivered a talk on “Research on Hemoglobinopathies” on May 26th 2023 in 2nd THALASSEMIA CONCLAVE-2023 organised by Department of Pathology & Department of Pediatrics at All India Institute of Medical Sciences, Bathinda.
  54. Delivered a talk on “Pharmacogenomics of breast cancer” on October 7th 2023 in CME & Workshop on vitrification: Fertility preservation in cancer, organised by Bathinda Obstetrics and Gynaecology Society and All India Institute of Medical Sciences, Bathinda and Jindal Heart Institute & Fertility Centre, Bathinda.
  55. Acted as chairperson in the plenary session of International Conference of Global Education Research Association in Hybrid Mode on Technology Impregnat Education and Community participation and Akhand Diashop on Mapping Life Skills of Rural Punjab on November 6 to 8, 2023 at Guru Kashi University, Talwandi Sabo.
  56. Served as a Committee Member in the Ten days “ Research Methodology Course”, held for M.Phil., Ph.D. and Post Doctoral Students, organized by Department of Geography, Central University of Punjab, Bathinda from 05th to 14th February 2024.
  57. Delivered a lecture on Monogenic Disorders: Focus on new molecular diagnostic approaches on 4th march 2024 as ‘Resource person’ in the Karyashala: Hands on Training on Sophisticated Instrumentation Techniques: Spectroscopy, Chromatography & Advanced Microscopy organized by Central Instrumentation Laboratory, Central University of Punjab under the Accelerate Vigyan Scheme (29 Feb, 2024 to 7th March, 2024), sponsored by Science and Engineering Research Board (SERB).
  58. Presented poster entitled “Evaluation of genetic variations rs9266 and rs712 with 3’UTR of KRAS genes and their functional implication on the binding of miRNA-181c and let-7c in Breast Cancer” at GLOBAL IMMUNOLOGY SUMMIT 2024 (GIS 2024) held on 15th to 17th February 2024, Organised by Translational Health Science and Technology Institute.
  59. Delivered an invited talk in 7th Two-Week Online Programme on “NEP Orientation & Sensitization Programme” on 27th of May 2024, Organised by Malaviya Mission Teacher Training Centre (MMTTC), (Online)
  60. Delivered a lecture on “ Innovation Enterpreneurship Ecosystem” in Leadership development programme, organised by Cemtral University of Punjab, Bathinda on 19th june 2024.
  61. Participated in Online Workshop on “Four Years of NEP 2020: Initiatives towards Internationalisation at the Institutional Level”, organised by the Unit for International Cooperation (UIC) at National Institute of Educational Planning and Administration (NIEPA), New Delhi, on 24-26 July 2024, 0930 Hrs-1330 Hrs [Half day session].
  62. K. Sohit, P. Vishal & M. Anjana presented a poster entitled “Triple negative breast cancer: A comprehensive review of genomic alterations, involved signalling pathways and therapeutic strategies” in National Conference on “E merging Trends in Cancer Prevention and Therapeutic Interventions” on 26th september 2024, organized by Central University of Punjab.
  63. C. Yogita & M. Anjana presented a poster entitled “Evaluation og genetic variation within 3’ UTR of KRAS genes and their functional implication on binding of miRNA-181c and let-7c in breast cancer” in National Conference on “E merging Trends in Cancer Prevention and Therapeutic Interventions” on 26th september 2024, organized by Central University of Punjab.
  64. C. Anita, S. Prachi, & M. Anjana presented a poster entitled “Oncogenic miRNAs in the development and progression of breast cancer” in National Conference on “E merging Trends in Cancer Prevention and Therapeutic Interventions” on 26th september 2024, organized by Central University of Punjab.
  65. Delivered an invited talk in the “Two week refresher course (onlone) in basic and applied sciences” on 04.10.2024 (Art of scientific writing and earning a grant) and on 07.10.2024 (Genetic disorders- An overview), organized by the UGC-Malviya Mission Teacher Training Centre, Guru Nanak Dev University, Amritsar. 
Conference/ Workshops/Seminars Organised
  1. Organized one day seminar on “Radiation Effects on Biology and Medicine” at the Institute of Genetics on 29th June, 2009, in collaboration with Indian Nuclear Society.
  2. Organized a 3 days conference on “Impact of Diseases and Social Issues Affecting Women and their Amelioration” at IICT auditorium on 12-14th December 2010 in collaboration with TWOWS (India).
  3. Organized a two days’ workshop on Fluorescent in situ Hybridization on 25th and 26th September, 2014 at Centre for Human Genetics, Central University of Punjab, Bathinda, Punjab.
  4. Organised 7 days STUTI workshop on Spectroscopic, Chromatographic, Bioanalytical & Imaging Techniques at Central University of Punjab in collaboration with Amity University, sponsored by Department of Science and Technology on 28th November – 04th December 2022.
  5. Organised one day National conference on “Basics of Research Methodology” on 3rd December, 2022 at Central University of Punjab in collaboration with AIIMS, Bathinda & Indian National Young Academy of Sciences (INYAS).
  6. Organised a workshop on “Basics of Systemic analysis and Meta-analysis” at Central University of Punjab in collaboration with AIIMS, Bathinda on 21st March, 2022.
  7. Organised a one day seminar and awareness program on “Pediatric Rare Genetic Disorders (PRaGeD)” on 10th August, 2023 at Central University of Punjab in collaboration with AIIMS, Bathinda.
  8. Organized  a two day National Conference on “Emerging Trends in Cancer Prevention and Therapeutic Interventions” as a chief organizer on 26-27th september 2024, by Central University of Punjab.

 

Peer Recognition
  • Section Editor, Therapeutic implications of Natural Compounds, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, Springer Nature
  • Section Editor, Frontiers in Genetics, Genetics of Common and rare diseases
  • Reviewer, PLoS One
  • Reviewer, International Journal of Stroke
  • Reviewer, BMC Medical Genetics
  • Reviewer, Annals of Neurology
  • Reviewer, International Journal of Cancer
  • Reviewer, Cellular and Molecular Biology Letters
  • Reviewer, Epilepsy Research
  • Reviewer, Scientific Reports
  • Reviewer, Journal of the Neurological Sciences
  • Reviewer, Journal of Cardiovascular Pharmacology 
  • Reviewer, Molecular Biology Reports
  • Reviewer, Cytokine
  • Reviewer, Indian Journal of Medical Research
  • Reviewer, Neurology India
Invited Talks/ Resource Person
1. A talk on “Nutrigenomics: Gene based personalized nutrition advice” in National seminar cum workshop on Food and women organized by Sarojininaiducentre for women studies, Mahatma Gandhi national institute of research and social action (MGNIRSA), Hyderabad on 21st&22nd of January 2011.
2. Delivered an invited talk on “Role of high throughput technologies in the management and control of the complex diseases” in the International conference on Biotechnological innovations towards global development, organized byDepartment of Biotechnology&Bioinformatics, Bishop Heber College (Autonomous), Tiruchirapalli, Tamil Nadu on 9th& 10thof January 2013
3. Invited Talk on “Recent Advances in the understanding of Genetic Architecture of Complex DiseasesUsing High Throughput Technologies” in Nation Seminar on Emerging Trends Challenges and Innovative Approaches in Clinical Research in India organized by BhagavanMahavirHospital on 27th-28th April at Hyderabad.
4. Invited talk on “Genetic influences in the pathogenesis of multifactorial ischemic stroke and its subtypes” in NeuroUpdate organized by Calcutta National Medical College, Govt. of West Bengal & CSIR-Indian Institute of Chemical Biology on 28th -29th November, 2014.
5. Invited talk on “PDE4D gene and ischemic stroke: Potential role for Phosphodiesterase inhibitors” New Frontiers in Diagnosis & Management of Genetic Diseases organized by Institute of Genetics & Hospital for Genetic Diseases, Osmania University, Hyderabadon 29th -30th of January, 2016.
6. Chaired a session “Epigenetics and Developmental Genetics” in 41st meeting of Indian Society of Human Genetics, Annual meeting and International conference entitled celebrating Genetics–The Human Way. Organized by Vision Research Foundation, Chennai on 3rd-5th March, 2016.
7. Delivered an invited talk on "Genomic signatures in ischemic stroke with disease susceptibility and outcome in the J&K women science congress entitled "Research and Women in Science, Technology and Mathematics- Representation, Challenges and Opportunities at P.G. College for Women Gandhi Nagar, Jammu, 26-28 Feb , 2019
8. Delivered an invited talk on "Genomic signatures in the development of ischemic stroke its subtypes and treatment outcome" Golden Jubilee National Seminar on Genetics of Complex Diseases at Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab on March 29, 2019.
9. Delivered a talk entitled “From a biology researcher to an academic administrator” in the webinar Women in Science, Education and Research organised by School of Life Sciences, Central University of Himachal Pradesh, India on 24th February 2021.
10. Delivered an expert talk on ‘ In-vitro and In-vivo Animal Models of Hemorrhage Stroke and Therapeutic Strategies” at Ganpat University, Shri S. K. Patel College of Pharmaceutical Education and Research, Gujarat, India on 7th and 8th August 2021
11. Delivered two talks entitled “Stroke “The Brain Attack” (21st January) and “The Art of Scientific Writing and Project Designing” (24 January) in “Refresher Course in Life Sciences” organised by Department of Botany, University of Jammu sponsored by the UGC-HRDC, through online platform from January 19, 2022 to February 02, 2022.
12. Delivered a talk entitled “Genomic signatures of Ischemic stroke susceptibility and Drug response” at 46th Annual Conference of Indian Society of Human Genetics (ISHG) held virtually between 8th and 9th of April, 2022. Manipal School of Life Sciences, MAHE, Manipal.
13. Delivered a talk on “DNA ‘The Blueprint of Life’ in a webinar on “Watson and Crick DNA Model Commemoration Day” on April 25, 2022 organized by Pushpa Gujral Science City, Kapurthala.


Contribution Towards Institutional Building
Instrumental in establishing the Department of Human Genetics and Molecular Medicine at Central University of Punjab
Resuscitation of Molecular Biology Lab at Institute of Genetics and Hospital of Genetic Diseases, Osmania University, Hyderabad
Establishment of Department of Genetics, Shadan Institute of Post Graduate Studies, Hyderabad
Citations
  • Google Scholar (Citations: 4182, h-index: 36, i10-index: 102)
  • Scopus (Citations: 2246, h-index: 27)
Community Participation
Provided molecular diagnostic services to all the referral cases (Total=5000) with following conditions, using HPLC, PCR, ARMS-PCR, Multiplex PCR, Reverse Dot Blot, RFLP and Sequencing:Thalassemia, Sickle cell anemia, Other structural variants of hemoglobin like E and D, Duchene Muscular Dystrophy, Stroke, Progeria, Neural Tube Defects.
Participated in the Thalassemia screening camp at Rangapur village, organized by Institute of Genetics and Hospital for Genetic Diseases, O U on 4.12.2008.
Participated in a free health camp for women organized by Institute of Genetics and Hospital for Genetic Diseases, O U at the Institute Premises on 8.3.2010.
Participated in the health camp organized at AP State home for Women and Children to screen women and children for general health conditions on 8.3.2010.
Participated in the health camp organized at Rangapur for ZillaParishad School children on 18.09.2010.
Curricular Development
Developed all the courses for M.Sc. and PhD Human Genetics offered by Department of Human Genetics and Molecular Medicine
Other Significant Achievements

Provided molecular diagnostic services to all the referral cases (Total=5000) with following conditions, using HPLC, PCR, ARMS-PCR, Multiplex PCR, Reverse Dot Blot, RFLP and Sequencing:Thalassemia, Sickle cell anemia, Other structural variants of hemoglobin like E and D, Duchene Muscular Dystrophy,  Stroke, Progeria,  Neural Tube Defects.